These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12323078)

  • 1. PKQuest: capillary permeability limitation and plasma protein binding - application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics.
    Levitt DG
    BMC Clin Pharmacol; 2002 Sep; 2():7. PubMed ID: 12323078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of the interstitial space in humans.
    Levitt DG
    BMC Clin Pharmacol; 2003 Jul; 3():3. PubMed ID: 12890292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.
    Levitt DG
    BMC Clin Pharmacol; 2002 Aug; 2():5. PubMed ID: 12182760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.
    Levitt DG
    BMC Res Notes; 2009 Aug; 2():158. PubMed ID: 19656378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.
    Levitt DG
    BMC Anesthesiol; 2002 Aug; 2(1):5. PubMed ID: 12182764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKQuest: measurement of intestinal absorption and first pass metabolism - application to human ethanol pharmacokinetics.
    Levitt DG
    BMC Clin Pharmacol; 2002 Aug; 2():4. PubMed ID: 12182761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of ceftriaxone.
    Popick AC; Crouthamel WG; Bekersky I
    Xenobiotica; 1987 Oct; 17(10):1139-45. PubMed ID: 3424863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the biological inactivation of high protein bound beta-lactam antibiotics in vitro.
    Henning C; Bergholm AM; Holm S
    APMIS; 1988 Nov; 96(11):997-1001. PubMed ID: 3196479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKQuest: PBPK modeling of highly lipid soluble and extracellular solutes.
    Levitt DG
    ADMET DMPK; 2019; 7(1):60-75. PubMed ID: 35350744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.
    Røder BL; Frimodt-Møller N; Espersen F; Rasmussen SN
    Infection; 1995; 23(2):107-12. PubMed ID: 7622258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulatory transport and capillary-tissue exchange as determinants of the distribution kinetics of inulin and antipyrine in dog.
    Weiss M; Krejcie TC; Avram MJ
    J Pharm Sci; 2007 Apr; 96(4):913-26. PubMed ID: 17221855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus.
    Yan D; Li J; Zhang Z; Zhu H
    Arch Orthop Trauma Surg; 2012 Jul; 132(7):969-73. PubMed ID: 22526195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference.
    Levitt DG
    BMC Clin Pharmacol; 2004 Feb; 4():2. PubMed ID: 15053829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human physiologically based pharmacokinetic model for propofol.
    Levitt DG; Schnider TW
    BMC Anesthesiol; 2005 Apr; 5(1):4. PubMed ID: 15847680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis.
    Kovar A; Dalla Costa T; Derendorf H
    J Pharm Sci; 1997 Jan; 86(1):52-6. PubMed ID: 9002459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and blood.
    Levitt DG
    BMC Clin Pharmacol; 2010 Jan; 10():1. PubMed ID: 20055995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein binding of dicloxacillin: effects of age and diseases.
    Pacifici GM; Viani A; Taddeucci-Brunelli G; Rizzo G; Carrai M
    Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):622-6. PubMed ID: 3429065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding.
    Cars O; Henning C; Holm SE
    Scand J Infect Dis; 1981; 13(1):69-74. PubMed ID: 7244562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamic target attainment of ceftriaxone in adult severely ill sub-Saharan African patients: a population pharmacokinetic modelling study.
    Bos JC; Prins JM; Mistício MC; Nunguiane G; Lang CN; Beirão JC; Mathôt RAA; van Hest RM
    J Antimicrob Chemother; 2018 Jun; 73(6):1620-1629. PubMed ID: 29522167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle capillary permeability for [14C]inulin and [51Cr]EDTA in human forearm.
    Keiding S; Henriksen O; Sejrsen P
    Acta Physiol Scand; 1988 Jul; 133(3):335-42. PubMed ID: 3147574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.